Most Recent

image: Decoding Breast Cancer Drug Resistance

Decoding Breast Cancer Drug Resistance

By | November 3, 2013

Common mutations in metastasized breast tumors suggest how the cancer can develop resistance to frontline drugs.

2 Comments

image: Book Excerpt from <em>Brave Genius</em>

Book Excerpt from Brave Genius

By | November 1, 2013

In Chapter 20, “On the Same Path,” author Sean Carroll describes the initial meeting between Nobel Laureates Jacques Monod and Albert Camus.

0 Comments

image: Chance and Necessity

Chance and Necessity

By | November 1, 2013

War and justice brought together two of the greatest minds of the 20th century, a scientist and a writer.

1 Comment

image: Contributors

Contributors

By | November 1, 2013

Meet some of the people featured in the November 2013 issue of The Scientist.

0 Comments

image: Penetrating the Brain

Penetrating the Brain

By | November 1, 2013

Researchers use molecular keys, chisels, and crowbars to open the last great biochemical barricade in the body—the blood-brain barrier.

3 Comments

image: Evolving Pain Resistance

Evolving Pain Resistance

By | October 24, 2013

Grasshopper mice harbor mutations in a pain-transmitting sodium channel that allow them to prey on highly toxic bark scorpions.

2 Comments

image: FDA Considers Three-Parent IVF

FDA Considers Three-Parent IVF

By | October 17, 2013

The US regulatory agency will meet next week to discuss whether to allow human trials of a technique that combines the genetic information of three adults.

0 Comments

image: Ketamine Alternative Shows Promise

Ketamine Alternative Shows Promise

By | October 17, 2013

Researchers show that lanicemine is an effective antidepressant without the adverse effects of the related hallucinogenic drug.

0 Comments

image: Italian Stem Cell Trial Stopped

Italian Stem Cell Trial Stopped

By | October 11, 2013

With support from scientists, Italy’s health minister halts a controversial clinical trial.

1 Comment

image: Clinical Silence

Clinical Silence

By | October 10, 2013

A study has shown that less than half of the outcomes of some clinical trials are publicly available.

0 Comments

Popular Now

  1. Gut Microbes Linked to Neurodegenerative Disease
  2. Top 10 Innovations 2016
    Features Top 10 Innovations 2016

    This year’s list of winners celebrates both large leaps and small (but important) steps in life science technology.

  3. Opinion: WHO’s Silence on Cannabis
  4. Image of the Day: Parting Ways
    Image of the Day Image of the Day: Parting Ways

    The Allen Institute for Cell Science releases the first public collection of human induced pluripotent stem cells that have been fluorescently tagged using CRISPR.

Rockland